Parag Patel, MD
Clinical Cardiac Electrophysiology · Rochester, NYNPI 1376757559
Payments from drug & device makers
Across 93 payments — averaging $168.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$7K
- Boston Scientific$4K
- Biotronik Inc.$2K
- Abiomed$664
- Medical Device Business Services, Inc.$554
- AstraZeneca$386
- plus $599 from 2 others
What the payments were for
- Consulting fees$2,00013%
- Speaking & faculty fees$2,60017%
- Travel & lodging$6,27840%
- Food & beverage$4,79231%
- Education$110%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 36 | $6,746 |
| Boston Scientific | 12 | $4,394 |
| Biotronik Inc. | 24 | $2,338 |
| Abiomed | 6 | $664 |
| Medical Device Business Services, Inc. | 3 | $554 |
| AstraZeneca | 4 | $386 |
| Biosense Webster, Inc. | 5 | $379 |
| Abbott | 3 | $220 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Micra$2,843
- EMBLEM MRI S-ICD$1,268
- Carto 3 System$724
- Solia$389
- Selectra$389
- Carto Smarttouch$233
- Acticor 7 VR-T DX$132
- Claria MRI$129
- AZURE XT DR MRI SURESCAN$128
- AVEIR$121
- RESONATE$113
- Rivacor 7 DR-T$109
- VIGILANT$109
How this compares
$15,680 in reported general payments places this provider in the 35th percentile of 214 clinical cardiac electrophysiology providers in New York.
See all clinical cardiac electrophysiology providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 189 | $236,518 |
| XareltoRivaroxaban | 39 | $45,245 |
| Dofetilide | 31 | $10,452 |
| JardianceEmpagliflozin | 12 | $9,619 |
| Amiodarone Hcl | 97 | $4,415 |
| Metoprolol Succinate | 150 | $3,131 |
| Flecainide Acetate | 49 | $1,818 |
| Warfarin Sodium | 77 | $1,287 |
| Rosuvastatin Calcium | 39 | $944 |
| Atorvastatin Calcium | 59 | $931 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 44 | $826 |
| Verapamil ErVerapamil Hcl | 23 | $665 |
| Losartan Potassium | 33 | $536 |
| SotalolSotalol Hcl | 15 | $317 |
| Amlodipine Besylate | 60 | $299 |
Paid to pharmacies, not to this prescriber.
Other clinical cardiac electrophysiology in Rochester
- David HuangRochester$2.2M
- Mehmet AktasRochester$416K
- Spencer RoseroRochester$101K
- Vivek ReddyNew York$16.7M
- Srinivas DukkipatiNew York$4.2M
- Jacob KoruthNew York$4M
- Stavros MountantonakisManhasset$2.6M
- Jorge RomeroSyracuse$2.6M
- Larry ChinitzNew York$2.6M
- James IpNew York$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.